Letter to Congress Correcting False Claims About Bayh-Dale Act and § 1498 on Drug Price Controls

On September 28th, 2023, a letter was sent to the Senate Health, Education, Labor and Pensions Committee, the Chair and Ranking Member of the House Ways and Means Committee, and to Secretary Becerra correcting false claims that the federal government can use the Bayh-Dole Act or § 1498 to impose price controls on prescription drugs.

The letter is signed by 25 scholars, former judges, and former government officials, including Judge Paul Michel, Judge Randall Rader, Judge Kathleen O’Malley, Judge Susan Braden, the Honorable Andrei Iancu, the Honorable Walter Copan, and the Honorable Ronald Cass.  It also includes leading scholars and patent and healthcare law experts, such as Jonathan Barnett, Richard Epstein, Emily Morris, Kristen Osenga, and Ted Sichelman, among many others.

Download the letter here: Letter to Congress – Bayh-Dole and 1498 Not Basis for Price Controls on Drug

Safeguarding Human Invention in the Age of Artificial Intelligence

By Alexander Kersten Introduction On October 30, President Joe Biden issued the Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence. This comes at a time when artificial intelligence (AI)’s anticipated capabilities and applications are expected to have a tremendous impact on the future
Read More

Dr. Kirti Gupta – Testimony: Innovating Ideas Around Standards and Intellectual Property

On September 20th, 2023, LeadershIP Executive Director Dr. Kirti Gupta testified for the ITA-NIST-USPTO Listening Session on Innovating Ideas Around Standards and Intellectual Property.    Transcript: Good afternoon. My name is Dr. Kirti Gupta and I am speaking on behalf of the Center for Strategic and International Studies (CSIS). Let
Read More

Four Actions to Strengthen the U.S. Intellectual Property System

By Hideki Tomoshige and Sujai Shivakumar A reliable and robust intellectual property (IP) system is a pillar of the nation’s innovation system. In an era when economic growth, global competitiveness, and national security are all predicated on relative strengths of national innovation systems, the United States needs to take deliberate
Read More